Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 Dicembre;57(4) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 Dicembre;57(4):367-80

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Rivista di Medicina Nucleare e Imaging Molecolare


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


eTOC

 

REVIEWS  DIAGNOSIS OF BREAST RECURRENCE


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 Dicembre;57(4):367-80

lingua: Inglese

Current and future perspectives in diagnostic imaging as a guide to targeted/local therapies in breast cancer recurrence

Evangelista L. 1, Mezzato C. 2, Felloni G. 2, Saladini G. 1

1 Radiotherapy and Nuclear Medicine Unit Veneto Institute of Oncology IOV - IRCCS, Padua, Italy;
2 Nuclear Medicine Service University of Padua, Padua, Italy


PDF  


In recent years, a multidisciplinary approach for breast cancer patient management has been adopted to provide an accurate evaluation of primary/recurrent tumor and to guiding appropriate treatment. The introduction of positron emission tomography (PET) and PET/computed tomography (CT) with 18F-fluorodeoxyglucose and other radiolabelled molecules for the early detection of breast cancer recurrence has important consequences both for staging and treatment planning. In particular, in the last few years, research efforts have been made to guide targeted or local therapies directing against the cancer outgrowth. Based on the available data in the literature, in the present review, we will discuss 1) the role of PET and PET/CT in guiding local therapies for breast cancer recurrences, (both loco-regional and distant sites); and 2) its current status in clinical practice and its possible future role.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail

laura.evangelista@ioveneto.it